Role of direct interaction in BRCA1 inhibition of estrogen receptor activity

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Oncogene

• Publication date

  2001-01-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1204073PMID 11244506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reducing the risk of breast cancer.

  2000cited by this paper
• BRCA1 interacts with components of the histone deacetylase complex.

  1999cited by this paper
• BRCA1 inhibition of estrogen receptor signaling in transfected cells.

  1999cited by this paper
• Emerging roles of BRCA1 in transcriptional regulation and DNA repair

  1999cited by this paper
• The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression*

  1998cited by this paper
• Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes

  1998cited by this paper
• Estrogen receptor activation function 1 works by binding p160 coactivator proteins.

  1998cited by this paper
• BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins

  1998influential reference
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part 2. Tumorigenic cell lines

  1997cited by this paper
• AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors

  1997cited by this paper
• Transcriptional activation by BRCA1

  1996cited by this paper
• Evidence for a transcriptional activation function of BRCA1 C-terminal region.

  1996cited by this paper
• Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

  1994cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994influential reference
• Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein.

  1993cited by this paper
• Structure of the human oestrogen-responsive gene pS2.

  1987cited by this paper
• Cloning and sequence analysis of cDNA for human cathepsin D.

  1985cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper

• The PER2:BRCA1:POU2F1(OCT-1) Ternary Complex Represents a Multi-Component Scaffold Model for Circadian Gene Regulation

  2025cites this paper
• Estrogen Therapies Enhance Mammary Carcinogenesis in Aging Gerbil Females Under Endocrine Disruption.

  2025cites this paper
• Recent Insights Into Breast Cancer: Molecular Pathways, Epigenetic Regulation, and Emerging Targeted Therapies

  2025cites this paper
• Alteration in estrogen receptor status in metachronous contralateral breast cancer among unilateral early breast cancer patients with BRCA 1/2 mutations.

  2025cites this paper
• Good Quality 66.7% 5-year Overall Survival in Terminal Lung Cancer Patients Treated With Mifepristone

  2025cites this paper
• Human Cancers Derived from Either Genetic or Lifestyle Factors Are Initiated by Impaired Estrogen Signaling

  2025cites this paper
• A New Class of BRCA1 Mimetics for ERα-Positive Breast Cancer Therapy: Design, Synthesis, In Silico Screening, In Vitro Assay, and Gene Expression Analysis

  2025cites this paper
• Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs)

  2024cites this paper
• Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer

  2024cites this paper
• The Role of Estrogen Receptors in Intracellular Estrogen Signaling Pathways, an overview.

  2024cites this paper
• A Novel Approach of High Dimensional Linear Hypothesis Testing Problem

  2024cites this paper
• DNA Damage Responses in Tumors Are Not Proliferative Stimuli, but Rather They Are DNA Repair Actions Requiring Supportive Medical Care

  2024cites this paper
• Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention

  2023cites this paper
• Phytochemical Loaded Nanovehicles of Biopolymer for Breast Cancer: A Systemic review

  2023cites this paper
• In Silico Identification of a BRCA1:miR-29:DNMT3 Axis Involved in the Control of Hormone Receptors in BRCA1-Associated Breast Cancers

  2023cites this paper
• Hormone replacement therapy for postmenopausal atherosclerosis is offset by late age iron deposition

  2023cites this paper
• Structure- and Energy-based Analysis of Small Molecule Ligand Binding to Steroid Nuclear Receptors

  2023cites this paper
• G-Quadruplex Matters in Tissue-Specific Tumorigenesis by BRCA1 Deficiency

  2022cites this paper
• BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy.

  2022cites this paper
• Modulation of BRCA1 mediated DNA damage repair by deregulated ER-α signaling in breast cancers.

  2022cites this paper
• The role of epigenetic modifications in drug resistance and treatment of breast cancer

  2022influential citation
• BRCA1: An Endocrine and Metabolic Regulator

  2022cites this paper
• The Interplay between the Cellular Response to DNA Double-Strand Breaks and Estrogen

  2022cites this paper
• [Therapeutic strategies for the treatment of endocrine resistant hormone receptor positive advanced breast cancer].

  2022cites this paper
• Acetylation of nuclear receptors in health and disease: an update

  2022cites this paper
• High BRCA1 gene expression increases the risk of early distant metastasis in ER+ breast cancers

  2022cites this paper
• The BRCA1/BARD1 ubiquitin ligase and its substrates.

  2021cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients

  2021cites this paper
• BRCA1-BARD1 regulates transcription through BRD4 in Xenopus nucleoplasmic extract

  2021cites this paper
• Compensatory Estrogen Signal Is Capable of DNA Repair in Antiestrogen-Responsive Cancer Cells via Activating Mutations

  2020cites this paper
• MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies

  2020cites this paper
• Dual Modulators of p53 and Cyclin D in ER Alpha Signaling by Albumin Nanovectors Bearing Zinc Chaperones for ER Positive Breast Cancer Therapy.

  2020cites this paper
• Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells

  2020cites this paper
• BRCA1-associated R-loop affects transcription and differentiation in breast luminal epithelial cells

  2019cites this paper
• Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review

  2019cites this paper
• CODA-ML: context-specific biological knowledge representation for systemic physiology analysis

  2019cites this paper
• Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer

  2019cites this paper
• BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance

  2019cites this paper
• Development and implementation of precision therapies targeting base-excision DNA repair in BRCA1-associated tumors

  2019cites this paper
• D-Type Cyclins and Gene Transcription

  2018cites this paper
• Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1/2 carrier cohort (GENEPSO).

  2018cites this paper
• Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance

  2018cites this paper
• BRCA1-Dependent Transcriptional Regulation: Implication in Tissue-Specific Tumor Suppression

  2018cites this paper
• RNF168 facilitates proliferation and invasion of esophageal carcinoma, possibly via stabilizing STAT1

  2018cites this paper
• D-type Cyclins and Cancer

  2018cites this paper
• Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis

  2018cites this paper
• RNF168 facilitates oestrogen receptor ɑ transcription and drives breast cancer proliferation

  2018cites this paper
• Integrative Bioinformatics and Functional Analyses of GEO, ENCODE, and TCGA Reveal FADD as a Direct Target of the Tumor Suppressor BRCA1

  2018cites this paper
• Chapter 8 Relationship of Breast Cancer with Ovarian Cancer

  2018cites this paper
• BRCA 1-Mimetic Compound NSC 35446 . Hcl Inhibits IKKB Expression by Reducing Estrogen Receptor-Occupancy in the IKKB Promoter and Inhibits NF-B Activity in Antiestrogen-Resistant Human Breast Cancer Cells

  2017cites this paper
• BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells

  2017cites this paper
• Characterization of mutations in BRCA1/2 and the relationship with clinic-pathological features of breast cancer in a hereditarily high-risk sample of chinese population

  2017cites this paper
• Translational Challenges and Therapeutic Opportunities in BRCA1-Related Breast Cancer

  2017cites this paper
• NF-κB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of BRCA1-Mutated Breast Cancer

  2017cites this paper
• Dual roles of DNA repair enzymes in RNA biology/post‐transcriptional control

  2016cites this paper
• Toosendanin Exerts an Anti-Cancer Effect in Glioblastoma by Inducing Estrogen Receptor β- and p53-Mediated Apoptosis

  2016cites this paper
• Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations

  2016cites this paper
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016cites this paper
• DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers

  2015cites this paper
• Relationship of Breast Cancer with Ovarian Cancer

  2015cites this paper
• ORAL CONTRACEPTIVES AS A RISK FACTOR FOR DEVELOPING BREAST CANCER IN BREAST CANCER (BRCA) GENE CARRIER FEMALE IN- THE 30-60 YEARS AGE GROUP: A META ANALYSIS

  2015cites this paper
• Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA 1 / 2 Carriers

  2015influential citation
• The Negative Elongation Factor Complex – a poorly understood multifaceted transcript-processing complex

  2015cites this paper
• BRCA1, a ‘complex’ protein involved in the maintenance of genomic stability

  2015cites this paper
• steroid hormone receptor action Historical Perspectives: An abridged history of sex

  2015cites this paper
• Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers

  2015influential citation
• Review The Negative Elongation Factor Complex – a poorly understood multi-faceted transcript-processing complex

  2015cites this paper
• Reproductive Cancer and Hormone Replacement

  2015cites this paper
• Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies

  2014cites this paper
• Award Number: W81XWH-11-1-0097 TITLE: The Role of Skp1-Cul1-F-box Ubiquitin Ligases in Src- Stimulated Estrogen Receptor Proteolysis and Estrogen Receptor Target Gene Expression PRINCIPAL INVESTIGATOR:

  2014cites this paper
• Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α.

  2014cites this paper
• Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.

  2014cites this paper
• Triple-negative breast cancer risk in women is increasing by the loss of estrogen supply or by defective estrogen signaling

  2014cites this paper
• Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications

  2014cites this paper
• Estrogen receptors as the novel therapeutic biomarker in non-small cell lung cancer.

  2014cites this paper
• Management of Hereditary Ovarian–Breast Cancer

  2014cites this paper
• Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development

  2014cites this paper
• Estrogen receptors are pivotal regulators of glucose uptake and energy expenditure

  2014cites this paper
• Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers

  2014cites this paper
• Analiza molekularna kompleksu genów MRE11/RAD50/NBS1 w rodzinach z agregacją zachorowań na raki piersi i/lub jajnika

  2014cites this paper
• Biochemical characterization of the estrogen receptor alpha (ERalpha) coactivator E6-Ap, SKPp2 and FBXL6

  2014cites this paper
• BRCA1 and Oxidative Stress

  2014cites this paper
• ASSOCIATION OF LIFESTYLE VARIABLES WITH THE NOVEL MUTATION OF BRCA1 GENE IN BREAST CANCER: A CASE- CONTROL STUDY AMONG THE BENGALEE HINDU FEMALES OF WEST BENGAL, INDIA.

  2014cites this paper
• Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy

  2013cites this paper
• Breast cancer risk in BRCA 1 mutation carriers : insight frommouse models

  2013cites this paper
• Comparative preclinical pharmacokinetics study of 3,3′-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?

  2013cites this paper
• BRCA1 Polymorphisms and Breast Cancer Epidemiology in the Western New York Exposures and Breast Cancer (WEB) Study

  2013cites this paper
• Pelvic high-grade serous carcinoma in BRCA1 and BRCA2 mutation carriers

  2013cites this paper
• Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue

  2013cites this paper
• Proteomic analysis of molecular biocompatibility of gold nanoparticles to human dermal fibroblasts-fetal.

  2013cites this paper
• Organizing principles of mammalian nonsense-mediated mRNA decay.

  2013cites this paper
• Breast cancer risk in BRCA1 mutation carriers: insight from mouse models.

  2013cites this paper
• The role of progesterone and the progesterone receptor in human reproduction and cancer

  2013cites this paper
• Expression of Estrogen-Related Gene Markers in Breast Cancer Tissue Predicts Aromatase Inhibitor Responsiveness

  2013cites this paper
• Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy

  2013cites this paper
• A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer

  2013cites this paper
• New roles of cyclin D1.

  2013cites this paper
• Circadian modulation of the estrogen receptor alpha transcription

  2012cites this paper
• TARGETING THE GENOTOXIC EFFECTS OF ESTROGENS.

  2012cites this paper